Rehmann Capital Advisory Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $262K | Buy |
2,673
+366
| +16% | +$35.8K | 0.03% | 272 |
|
|
2019
Q2 | $302K | Buy |
2,307
+14
| +0.6% | +$1.83K | 0.04% | 351 |
|
|
2019
Q1 | $310K | Buy |
2,293
+588
| +34% | +$79.5K | 0.04% | 321 |
|
|
2018
Q4 | $166K | Sell |
1,705
-1,228
| -42% | -$120K | 0.02% | 284 |
|
|
2018
Q3 | $408K | Buy |
2,933
+283
| +11% | +$39.3K | 0.06% | 245 |
|
|
2018
Q2 | $329K | Sell |
2,650
-73
| -3% | -$9.06K | 0.05% | 274 |
|
|
2018
Q1 | $304K | Buy |
+2,723
| New | +$304K | 0.05% | 276 |
|
|
2017
Q4 | – | Sell |
-1,719
| Closed | -$241K | – | 405 |
|
|
2017
Q3 | $241K | Buy |
+1,719
| New | +$241K | 0.04% | 318 |
|
|
2016
Q1 | – | Sell |
-1,112
| Closed | -$212K | – | 397 |
|
|
2015
Q4 | $212K | Buy |
+1,112
| New | +$212K | 0.04% | 310 |
|
|
2015
Q1 | – | Sell |
-1,081
| Closed | -$200K | – | 361 |
|
|
2014
Q4 | $200K | Buy |
+1,081
| New | +$200K | 0.05% | 317 |
|